Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleBrief Communication

Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting

Kathleen Marsh, Kayla Allickson, Amanda Jesz, Cheryl Hanson, Donna Newman and Erica Martin-Macintosh
Journal of Nuclear Medicine Technology March 2025, 53 (1) 68-71; DOI: https://doi.org/10.2967/jnmt.124.268039
Kathleen Marsh
1Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayla Allickson
2Department of Diagnostic Radiology, Sanford Health, Fargo, North Dakota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Jesz
2Department of Diagnostic Radiology, Sanford Health, Fargo, North Dakota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl Hanson
2Department of Diagnostic Radiology, Sanford Health, Fargo, North Dakota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna Newman
2Department of Diagnostic Radiology, Sanford Health, Fargo, North Dakota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Martin-Macintosh
2Department of Diagnostic Radiology, Sanford Health, Fargo, North Dakota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 53 no. 1 68-71
DOI 
https://doi.org/10.2967/jnmt.124.268039
PubMed 
39909587

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication September 21, 2024
  • Accepted for publication January 7, 2025
  • Published online March 5, 2025.

Article Versions

  • previous version (February 5, 2025 - 07:47).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2025 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Kathleen Marsh1,
  2. Kayla Allickson2,
  3. Amanda Jesz2,
  4. Cheryl Hanson2,
  5. Donna Newman2 and
  6. Erica Martin-Macintosh2
  1. 1Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota; and
  2. 2Department of Diagnostic Radiology, Sanford Health, Fargo, North Dakota
  1. For correspondence or reprints, contact Kathleen Marsh (Kathleenmarsh5{at}gmail.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: February 2025 to April 2025

AbstractFullPdf
Feb 20256912815
Mar 2025369227
Apr 2025215136
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting
Kathleen Marsh, Kayla Allickson, Amanda Jesz, Cheryl Hanson, Donna Newman, Erica Martin-Macintosh
Journal of Nuclear Medicine Technology Mar 2025, 53 (1) 68-71; DOI: 10.2967/jnmt.124.268039

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting
Kathleen Marsh, Kayla Allickson, Amanda Jesz, Cheryl Hanson, Donna Newman, Erica Martin-Macintosh
Journal of Nuclear Medicine Technology Mar 2025, 53 (1) 68-71; DOI: 10.2967/jnmt.124.268039
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Patient Motion During Cardiac PET Imaging
  • Fitness for Purpose of Text-to-Image Generative Artificial Intelligence Image Creation in Medical Imaging
Show more Brief Communication

Similar Articles

Keywords

  • radiation therapy planning
  • lutetium 177
  • prostate
  • metastatic
  • radiation safety
  • radioligand
SNMMI

© 2025 SNMMI

Powered by HighWire